3Gambacorti C,Talpaz M. Sawyers C Five years followup resuits of a phase Ⅱ trial in patients with late chronic phase chronic myeloid leukemia treated with imatinib who are intolerant of intederon-α[J].Blood,2005.1072-1089.
4张之南;沈悌.血液病诊断及疗效标准[M]北京:人民卫生出版社,2007134-138.
5Kayastha GK,Gurung P,Acharya PK. Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate);the first generation specific tyrosine kinase inhibitor[J].BMC Blood Disorders,2010,(01):8.doi:10.1186/1471-2326-10-8.
6Maekawa T,Ashihara E,Kimura S. The Bcr-Abl tyrosine kinase inhibitor inatinib and prorising new gents against Philadelphia chromosome-positive leukemias[J].International Journal of Clinical Oncology,2007,(05):327-340.
